文献速递甲状腺与浅表介入US

微波消融与手术治疗超声发现轻微甲状腺外侵犯的甲状腺乳头状癌:一项多中心前瞻性研究

Microwave ablation vs. surgery for papillary thyroid carcinoma with minimal sonographic extrathyroid extension: a multicentre prospective study.
PubMed 文献 · Eur Radiol · 2022-06-30

这项多中心前瞻性研究纳入10家医院198例术前超声评估为T1N0M0且伴轻微甲状腺外侵犯的甲状腺乳头状癌患者,92例选择微波消融、106例选择手术;两组技术成功率均为100%,随访期间肿瘤学结局相似(均p>0.05),微波消融组手术时间更短、出血更少、费用更低,并发症发生率两组无显著差异,手术组瘢痕问题和焦虑评分更高。

要点

  • 超声评估为T1N0M0伴轻微甲状腺外侵犯的甲状腺乳头状癌,微波消融与手术短期疗效和安全性相当。
  • 微波消融采用水隔离下扩大消融,两组技术成功率均为100%。
  • 手术组瘢痕问题评分和焦虑评分均高于微波消融组(p<0.001和p=0.003)。

核心结论

  • 在经超声检出的T1N0M0伴轻微甲状腺外侵犯的甲状腺乳头状癌选择病例中,微波消融短期内的治疗安全性和疗效与手术相当。

研究设计与样本

  • 多中心前瞻性研究,2019年12月至2021年4月纳入10家医院198例术前超声评估为T1N0M0伴轻微甲状腺外侵犯的甲状腺乳头状癌患者,92例选择微波消融、106例选择手术;微波消融采用水隔离下扩大消融,手术方式包括腺叶切除加同侧中央区淋巴结清扫、腺叶及峡部切除加同侧中央区淋巴结清扫和全甲状腺切除加同侧中央区淋巴结清扫。

诊断标准与关键数值

  • 微波消融组与手术组技术成功率均为100%。
  • 随访期间两组肿瘤学结局相似(均p>0.05)。
  • 微波消融组并发症3例(3.3%),手术组4例(3.8%)(p=0.846)。
  • 手术组瘢痕问题评分(p<0.001)和焦虑评分(p=0.003)均高于微波消融组。

临床应用与阅片要点

  • 术前超声评估T1N0M0伴轻微甲状腺外侵犯的甲状腺乳头状癌患者,微波消融采用水隔离下扩大消融,可作为与手术比较的短期选择之一。
  • 微波消融组手术时间更短、出血更少、费用更低(均p<0.001)。
  • 随访时间微波消融组12.7±4.1个月、手术组12.6±5.0个月,两组肿瘤学结局相似。

局限性

  • 随访时间微波消融组为12.7±4.1个月、手术组为12.6±5.0个月,仅反映短期结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Minimal extrathyroid extension (mETE) was removed from the TNM staging system. This study was designed prospectively to compare the safety and efficacy of microwave ablation (MWA) versus surgery for treating T1N0M0 papillary thyroid carcinomas (PTC) with sonographically detected mETE.

METHODS: From December 2019 to April 2021, 198 patients with T1N0M0 mETE-PTCs evaluated by preoperative ultrasound from 10 hospitals were included. Ninety-two patients elected MWA, and 106 patients elected surgery for treatment. MWA was performed using extensive ablation with hydrodissection. Surgery consisted of lobectomy with ipsilateral central lymph node dissection (CLD), lobe and isthmus excision with ipsilateral CLD and total thyroidectomy with ipsilateral CLD. The rates of technical success, cost, oncologic outcomes, complications and quality of life of the two groups were assessed.

RESULTS: The follow-up times for the MWA and surgery groups were 12.7 ± 4.1 and 12.6 ± 5.0 months, respectively. The technical success rate was 100% for both groups. Oncological outcomes of the two groups were similar during the follow-up (all p > 0.05). The MWA group had a shorter operation time, less blood loss and lower costs (all p < 0.001). Three complications (3.3%) were reported in the MWA group and 4 (3.8%) in the surgery group (p = 0.846). The surgery group had higher scores for scar problems and anxiety (p < 0.001 and p = 0.003, respectively).

CONCLUSIONS: Microwave ablation was comparable in the short term to surgery in terms of treatment safety and efficacy in selected patients with T1N0M0 mETE-PTC detected by ultrasound.

KEY POINTS: • Microwave ablation is comparable to surgery in the safety and short-term efficacy for PTCs with sonographically detected mETE. • Thermal ablation is technically feasible for mETE-PTC treatment. • Patients with mETE-PTC have similar quality of life in the two groups, except for worse scar problems and anxiety in the surgery group.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zheng, Dou, Liu, et al. Microwave ablation vs. surgery for papillary thyroid carcinoma with minimal sonographic extrathyroid extension: a multicentre prospective study. Eur Radiol. 2022. PMID: 35771248. doi:10.1007/s00330-022-08962-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。